Can i get an educated answer to the following questions?
When will HNAB shares quadruple in value? I hope I'm not wasting my time here. When will it double? I don't even know why I bought this stock. I think it was because it was so cheap at $6.00 as I watched it go from 8 to 9 to 8 to 7 to 6. but now it is approaching high $4.00s. When will it reach the analyst estimate of $16/share?
It would be in your best interest to answer this question or else I might sell all my shares and cause a short scare.
I'll take the injection - it hurts less. Plus I get the headaches to match.
Sounds like a dream drug.
These guys dropped sales guidance becuase "of changes in the chemotherapy-induced nausea and vomiting market."
"Generic versions of an anti-nausea treatment that competes with Aloxi became available in the fourth-quarter, causing Aloxi's net selling price to drop and sales to decline."
Could it be that they see HNAB as a this change? The generic is the zophran generic thing, which we all know is not new.
This is not real news because it is an inferior drug and they are lowering guidance because of HNAB and the generic. If anything, this bolsters the case for HNAB as it is viewed by MGI to be a threat for taking away market share.
Why not take half of the position and buy another stock that has a great future with FDA approvals and hold what is left, wait for this to begain to move off it's low. Still not to late to buy some stocks that have recently made a move but still under the radar. HTI comes to mind. GOOD LUCK IN TRADING!